Oregon Public Employees Retirement Fund’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.34M Buy
12,658
+300
+2% +$31.8K 0.02% 628
2025
Q1
$1.53M Buy
12,358
+8
+0.1% +$993 0.03% 527
2024
Q4
$1.52M Sell
12,350
-272
-2% -$33.5K 0.03% 558
2024
Q3
$1.41M Sell
12,622
-500
-4% -$55.7K 0.03% 608
2024
Q2
$1.4M Sell
13,122
-2,456
-16% -$262K 0.03% 566
2024
Q1
$1.88M Sell
15,578
-8,576
-36% -$1.03M 0.04% 472
2023
Q4
$2.97M Sell
24,154
-3,400
-12% -$418K 0.05% 324
2023
Q3
$3.57M Sell
27,554
-4,735
-15% -$613K 0.05% 350
2023
Q2
$4M Buy
32,289
+4,939
+18% +$612K 0.05% 359
2023
Q1
$4M Sell
27,350
-710
-3% -$104K 0.05% 354
2022
Q4
$4.47M Buy
28,060
+642
+2% +$102K 0.06% 330
2022
Q3
$3.66M Sell
27,418
-343
-1% -$45.7K 0.05% 343
2022
Q2
$4.33M Sell
27,761
-5,030
-15% -$785K 0.07% 268
2022
Q1
$5.11M Sell
32,791
-1,432
-4% -$223K 0.05% 377
2021
Q4
$4.36M Hold
34,223
0.05% 337
2021
Q3
$4.46M Buy
34,223
+533
+2% +$69.4K 0.05% 319
2021
Q2
$5.99M Buy
33,690
+2,241
+7% +$398K 0.07% 273
2021
Q1
$5.17M Buy
31,449
+239
+0.8% +$39.3K 0.06% 279
2020
Q4
$5.15M Sell
31,210
-3,109
-9% -$513K 0.07% 262
2020
Q3
$4.89M Buy
34,319
+17,746
+107% +$2.53M 0.07% 238
2020
Q2
$1.83M Buy
16,573
+2,400
+17% +$265K 0.03% 519
2020
Q1
$1.41M Sell
14,173
-1,200
-8% -$120K 0.02% 560
2019
Q4
$2.3M Buy
15,373
+2,400
+18% +$358K 0.03% 514
2019
Q3
$1.66M Buy
12,973
+367
+3% +$47K 0.02% 699
2019
Q2
$1.8M Buy
12,606
+3,100
+33% +$442K 0.02% 654
2019
Q1
$1.36M Buy
9,506
+330
+4% +$47.2K 0.02% 788
2018
Q4
$1.14M Buy
9,176
+2,939
+47% +$364K 0.02% 827
2018
Q3
$1.05M Buy
6,237
+63
+1% +$10.6K 0.01% 954
2018
Q2
$1.06M Buy
+6,174
New +$1.06M 0.02% 942
2016
Q3
Sell
-300
Closed -$42K 958
2016
Q2
$42K Hold
300
﹤0.01% 997
2016
Q1
$39K Buy
300
+100
+50% +$13K ﹤0.01% 999
2015
Q4
$28K Hold
200
﹤0.01% 1016
2015
Q3
$27K Hold
200
﹤0.01% 1015
2015
Q2
$35K Sell
200
-2,900
-94% -$508K ﹤0.01% 1013
2015
Q1
$536K Buy
3,100
+100
+3% +$17.3K 0.01% 903
2014
Q4
$491K Buy
+3,000
New +$491K 0.01% 909